⏳ Fetching live dividend data...
Home › Calculator › PMXSF Dividend Calculator 2026
Pharmaxis Ltd · OTC
Price: $0.03 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in PMXSF → $2.5854992086640227e+30M in 10 years · $215,455,532,113,358,500,000,000,000,000,000,000.00/month
Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol Respiratory Business and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper-responsive airways, as well as to assist in diagnosing and managing asthma. The company's product pipeline consists of oral pan-lysyl oxidase inhibitors (LOX) targeting myelofibrosis and other cancers; topical pan-LOX inhibitors targeting skin scarring after events, such as accidents, surgery,and burns; selective Lysyl Oxidase Like Inhibitors (LOXL2) targeting chronic fibrotic diseases, including kidney fibrosis, pulmonary fibrosis, liver fibrosis, and cardiac fibrosis; and semicarbazide-sensitive amine oxidase for neuro inflammatory diseases. It is also developing Orbital, a dry powder inhaler to deliver high drug doses to lungs. Pharmaxis Ltd was incorporated in 1998 and is headquartered in Frenchs Forest, Australia.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open PMXSF position with:
Real after-tax yield depends on where you live and how you hold PMXSF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 7692.31% | 7689.51% | $769,231 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 6538.46% | 6535.66% | $653,846 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 6153.85% | 6151.05% | $615,385 / yr |
| 🇬🇧 UK ISA | 0% | 7692.31% | 7689.51% | $769,231 / yr |
| 🇬🇧 UK Taxable | 8.75% | 7019.23% | 7016.43% | $701,923 / yr |
| 🇨🇦 TFSA | 0% | 7692.31% | 7689.51% | $769,231 / yr |
| 🇨🇦 CA Taxable | 25% | 5769.23% | 5766.43% | $576,923 / yr |
| 🇦🇺 Super (pension) | 15% | 6538.46% | 6535.66% | $653,846 / yr |
| 🇦🇺 AU Taxable | 30% | 5384.62% | 5381.82% | $538,462 / yr |
| 🇩🇪 DE Taxable | 26.375% | 5663.46% | 5660.66% | $566,346 / yr |
| 🇫🇷 FR Taxable | 30% | 5384.62% | 5381.82% | $538,462 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
PMXSF pays quarterly — 4 times per year. Next ex-div: TBD.
How PMXSF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PMXSF sourced from FMP /financial-growth endpoint — real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PMXSF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →